Royal Bank of Canada
ARGS

Royal Bank of Canada’s Argos Therapeutics, Inc. ARGS Stock Holding History

Royal Bank of Canada’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-66
Closed – – 7118
2018
Q1 		$0 Sell
66
-2
-3% -$4 ﹤0.01% 7298
2017
Q4 		$0 Sell
68
-15
-18% -$50 ﹤0.01% 7412
2017
Q3 		$0 Sell
83
-480
-85% -$2.3K ﹤0.01% 7389
2017
Q2 		$4K Sell
563
-748
-57% -$6.37K ﹤0.01% 6160
2017
Q1 		$11K Buy
1,311
+1,225
+1,424% +$77.5K ﹤0.01% 5949
2016
Q4 		$9K Buy
86
+46
+115% +$4.3K ﹤0.01% 6144
2016
Q3 		$4K Hold
40
– – ﹤0.01% 6071
2016
Q2 		$5K Hold
40
– – ﹤0.01% 5987
2016
Q1 		$5K Buy
40
+14
+54% +$1.13K ﹤0.01% 5954
2015
Q4 		$1K Hold
26
– – ﹤0.01% 6593
2015
Q3 		$2K Hold
26
– – ﹤0.01% 6443
2015
Q2 		$3K Sell
26
-4
-13% -$639 ﹤0.01% 6354
2015
Q1 		$5K Hold
30
– – ﹤0.01% 5774
2014
Q4 		$6K Buy
30
+10
+50% +$1.8K ﹤0.01% 5791
2014
Q3 		$4K Buy
20
+5
+33% +$781 ﹤0.01% 5722
2014
Q2 		$2K Hold
15
– – ﹤0.01% 5786
2014
Q1 		$3K Buy
+15
New +$3K ﹤0.01% 5714

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Royal Bank of Canada's ARGS Position: Q2 2018 in Review

Royal Bank of Canada sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2018, closing a stake of 66 shares.

Royal Bank of Canada first reported a position in ARGS in Q1 2014 and held it in 17 quarters. The position peaked at $11K in Q1 2017. 4 funds tracked by Wall St. Rank hold ARGS as of Q2 2018.

  • Royal Bank of Canada reported no remaining Argos Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 66 Argos Therapeutics, Inc. shares in Q2 2018.
  • Royal Bank of Canada first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 17 quarters.
  • Royal Bank of Canada's Argos Therapeutics, Inc. position peaked at $11K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2018.

Based on Royal Bank of Canada's 13F filing for Q2 2018, filed 14 Aug 2018.